Cabaletta Bio gains on FDA fast-track tags for lead asset
https://seekingalpha.com/news/4053209-cabaletta-bio-gains-fda-fast-track-tags-lead-asset?source=feed_sector_healthcare
Jan 08, 2024 - Cabaletta Bio's (CABA) stock rose after the FDA granted additional fast-track designations for its lead candidate in autoimmune conditions. Read more here.
0
SomaLogic board urges shareholders to approve Standard Bio Tools merger
https://seekingalpha.com/news/4051340-somalogic-board-urges-shareholders-to-approve-standard-bio-tools-merger?source=feed_sector_healthcare
Dec 29, 2023 - SomaLogic’s (SLGC) board of directors has issued an open letter to stockholders urging them to vote for a proposed merger with Standard Bio Tools (LAB). Read more here.
0
Are You Looking for a Top Momentum Pick? Why Third Harmonic Bio, Inc. (THRD) is a Great Choice
https://www.zacks.com/stock/news/2203802/are-you-looking-for-a-top-momentum-pick-why-third-harmonic-bio-inc-thrd-is-a-great-choice?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2203802
Dec 29, 2023 - Does Third Harmonic Bio, Inc. (THRD) have what it takes to be a top stock pick for momentum investors? Let's find out.
0
Senti Bio (SNTI) Rises as FDA Clears IND for Cancer Candidate
https://www.zacks.com/stock/news/2202282/senti-bio-snti-rises-as-fda-clears-ind-for-cancer-candidate?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2202282
Dec 26, 2023 - The FDA clears Senti Bio's (SNTI) investigational new drug application for SENTI-202 for the treatment of relapsed/refractory hematologic malignancies, including acute myeloid leukemia. Stock rises.
0
Vyant Bio files Certificate of Dissolution with State of Delaware
https://seekingalpha.com/news/4050298-vyant-bio-files-certificate-of-dissolution-with-state-of-delaware?source=feed_sector_healthcare
Dec 26, 2023 - Vyant Bio's Board of Directors has filed for dissolution, ending trading on the OTC.
0
Should You Invest in Bluebird Bio Right Now?
https://www.fool.com/investing/2023/12/26/should-you-invest-in-bluebird-bio-right-now/?source=iedfolrf0000001
Dec 26, 2023 - After two December share price crashes, there's no evident cure for Bluebird Bio's ills.
0
If You Invested $10,000 in Bluebird Bio In 2021, This Is How Much You Would Have Today
https://www.fool.com/investing/2023/12/24/if-you-invested-10000-in-bluebird-bio-in-2018-this/?source=iedfolrf0000001
Dec 24, 2023 - Can things get better for this struggling stock?
0
1 Green Flag and 1 Red Flag for Bluebird Bio Stock
https://www.fool.com/investing/2023/12/23/1-green-flag-and-1-red-flag-for-bluebird-bio-stock/?source=iedfolrf0000001
Dec 23, 2023 - The stock has been in the news lately.
0
Passage Bio stock climbs 9% on dementia study, program update
https://seekingalpha.com/news/4048762-passage-bio-stock-climbs-on-dementia-study-program-update?source=feed_sector_healthcare
Dec 20, 2023 - Passage Bio (PASG) shares surged 9% on encouraging Phase 1/2 data for gene therapy candidate PBFT02 in treating FTD-GRN, a type of early onset dementia. Read more here.
0
bluebird bio announces proposed public offering of common stock
https://seekingalpha.com/news/4047685-bluebird-bio-announces-proposed-public-offering-of-common-stock?source=feed_sector_healthcare
Dec 18, 2023 - bluebird bio (BLUE) announces an underwritten public offering of $150M of its common stock, with proceeds to support gene therapies and general purposes.
0